Dissecting the mechanisms of the PD‐L1‐driven tumorigenesis of NF2‐associated meningioma will help to improve our understanding of the mechanisms underlying tumor progression and could facilitate the further refinement of current therapies to improve the treatment of NF2 patients. The gene discussed is NF2; the disease is neoplasm.